Young AD sufferers may benefit from probiotic

AN independent study conducted by the University of Copenhagen and published in the Journal of Probiotics and Prebiotics (Vol. 5, No. 2, pp. 53-60, 2010) shows possible benefit from Danisco's Bi-07™ probiotic for young children, aged 7-24 months, with atopic dermatitis (AD). Researchers evaluated the clinical and immunological changes of AD (also known as eczema) after consumption of Danisco's probiotic strains Lactobacillus acidophilus NCFM® and Bifidobacterium animalis subsp. lactis Bi-07™. The study involved a double blind, randomised, placebo-controlled intervention in which 50 infants and toddlers with AD were given supplements containing one of the probiotics (each at 1010 CFU/day) or a placebo for 8 and safety. Mr Zhang will be responsible for NSF Shanghai's joint venture operations, directing NSF International's range of auditing, product certification and registration services. He also will coordinate with NSF International's 31 global locations, eight of which are located throughout the Asia-Pacific region. Mr Zhang studied mechanical engineering at the University of Leuven in Belgium and earned master's and bachelor's degrees in applied mechanics from Fudan University in Shanghai. NSF Asia Pacific Co Ltd T: +66 2 650 3080 F: +66 2 650 3084 Email: asia@nsf.org Web: www.nsf.org

FPE508

NSF Shanghai Co Ltd T:+86 (0) 21 5080 1188 F: 86 (0) 21 5080 1199 Email: info@nsf.org.cn Web: www.nsf.org.cnNike